These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34149679)

  • 1. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
    Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
    Front Immunol; 2021; 12():568789. PubMed ID: 34149679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
    Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
    Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.
    Li X; Liu L; Yang Y; Yang X; Wang C; Li Y; Ge Y; Shi Y; Lv P; Zhou H; Luo P; Huang S
    Int Immunopharmacol; 2021 Jan; 90():107022. PubMed ID: 33160854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection.
    Minutolo A; Petrone V; Fanelli M; Maracchioni C; Giudice M; Teti E; Coppola L; Sorace C; Iannetta M; Tony Miele M; Bernardini S; Mastino A; Sinibaldi Vallebona P; Balestrieri E; Andreoni M; Sarmati L; Grelli S; Garaci E; Matteucci C
    Int Immunopharmacol; 2023 May; 118():110055. PubMed ID: 36989892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing.
    Bai H; Liang L; Qi X; Xu Y; Liu Y; Ren D; Cai Z; Mao W; Wang X; Qin H; Hu F; Shi B
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110983. PubMed ID: 37769533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV.
    Chen C; Wang J; Xun J; Zhang X; Liu L; Song Z; Zhang R; Chen J; Lu H
    BMC Infect Dis; 2024 Jan; 24(1):97. PubMed ID: 38233816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of thymosin alpha 1 with mutant IgG1 CH3 prolongs half-life and enhances antitumor effects in vivo.
    Shen X; Wang L; Xu C; Yang J; Peng R; Hu X; Wang F; Zheng H; Lao X
    Int Immunopharmacol; 2019 Sep; 74():105662. PubMed ID: 31220695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.
    Liu J; Shen Y; Wen Z; Xu Q; Wu Z; Feng H; Li Z; Dong X; Huang S; Guo J; Zhang L; Chen Y; Li W; Zhu W; Du H; Liu Y; Wang T; Chen L; Teboul JL; Annane D; Chen D
    Front Immunol; 2021; 12():673693. PubMed ID: 34408744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
    Mao L
    Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
    Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
    Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.
    Shehadeh F; Benitez G; Mylona EK; Tran QL; Tsikala-Vafea M; Atalla E; Kaczynski M; Mylonakis E
    J Infect Dis; 2023 Jan; 227(2):226-235. PubMed ID: 36056913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
    Hadden JW; Verastegui E; Hadden E
    Ann N Y Acad Sci; 2007 Sep; 1112():245-55. PubMed ID: 17600288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain.
    Cantenys-Molina S; Fernández-Cruz E; Francos P; Lopez Bernaldo de Quirós JC; Muñoz P; Gil-Herrera J
    Clin Exp Immunol; 2021 Mar; 203(3):424-432. PubMed ID: 33187018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.
    Jia Z; Feng Z; Tian R; Wang Q; Wang L
    Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ and CD8+ cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: a retrospective study.
    Liana P; Samosir AP; Sari NP; Andriani RAL; Verdiansah V; Hidayatullah H; Ahmad Z; Umar TP
    PeerJ; 2023; 11():e15509. PubMed ID: 37377785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.